CLINICAL TRIALS PROFILE FOR BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
✉ Email this page to a colleague
All Clinical Trials for betamethasone dipropionate; clotrimazole
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02582177 ↗ | Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis | Completed | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | 2019-06-11 | To evaluate the no-inferiority of the ketoconazole20mg/g and betamethasone dipropionate 0.64 mg/g association (Candicort®) cream versus clotrimazole 10mg and dexamethasone acetate 0.443 mg/g association (Baycuten N®) cream, general relief of signs and symptoms (erythema, maceration, peeling, blistering / papules / pustules, itching and burning / stinging) 06 (± 1) days after onset treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for betamethasone dipropionate; clotrimazole
Condition Name
Clinical Trial Locations for betamethasone dipropionate; clotrimazole
Clinical Trial Progress for betamethasone dipropionate; clotrimazole
Clinical Trial Phase
Clinical Trial Sponsors for betamethasone dipropionate; clotrimazole
Sponsor Name